Global Skin Infections Analysis and Research 2013

MarketResearchReports.Biz announces addition of new report “Global Skin Infections Analysis And Research 2013” to its database


Albany, NY -- (SBWIRE) -- 01/22/2014 -- Skin Infections - Pipeline Review, H2 2013

Global Markets Directs, 'Skin Infections - Pipeline Review, H2 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Skin Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Skin Infections. Skin Infections - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team.

Browse Complete report with TOC :

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


- A snapshot of the global therapeutic scenario for Skin Infections.
- A review of the Skin Infections products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Skin Infections pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

To Download Sample Report Visit @

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Skin Infections.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Skin Infections pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

To buy a copy of this Report:

Table of Contents

Table of Contents
List of Tables
List of Figures
Global Markets Direct Report Coverage
Skin Infections Overview
Therapeutics Development
Pipeline Products for Skin Infections - Overview
Pipeline Products for Skin Infections - Comparative Analysis
Skin Infections - Therapeutics under Development by Companies
Skin Infections - Therapeutics under Investigation by Universities/Institutes
Skin Infections - Pipeline Products Glance
Late Stage Products
Clinical Stage Products
Early Stage Products
Skin Infections - Products under Development by Companies
Skin Infections - Products under Investigation by Universities/Institutes
Skin Infections - Companies Involved in Therapeutics Development

Contact US:
Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States

Toll Free: 866-997-4948
Tel: +1-518-618-1030